Cargando…
Specific classification and new therapeutic targets for neuroendocrine prostate cancer: A patient-based, diagnostic study
Objective: Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer (PC) that may arise de novo or in patients previously treated with hormonal therapies for prostate adenocarcinoma as a mechanism of resistance. In our investigation, there appeared to be a strong correlation...
Autores principales: | Wang, YouZhi, Wu, Ning, Wang, KeKe, Liao, YiHao, Guo, JiaNing, Zhong, BoQiang, Guo, Tao, Liang, JiaMing, Jiang, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479159/ https://www.ncbi.nlm.nih.gov/pubmed/36118857 http://dx.doi.org/10.3389/fgene.2022.955133 |
Ejemplares similares
-
Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer
por: Wu, Ning, et al.
Publicado: (2022) -
BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway
por: Jiang, Ning, et al.
Publicado: (2021) -
MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma
por: Zhong, Boqiang, et al.
Publicado: (2023) -
OTUB1 Promotes Progression and Proliferation of Prostate Cancer via Deubiquitinating and Stabling Cyclin E1
por: Liao, Yihao, et al.
Publicado: (2021) -
Ferroptosis landscape in prostate cancer from molecular and metabolic perspective
por: Liang, Jiaming, et al.
Publicado: (2023)